Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System — Stella

Recruiting

Back to Stress Urinary Incontinence trials

Trial locations(4 sites)

United States

Institute for Female Pelvic Medicine, North Wales, Pennsylvania

Italy

Bio-Medical University Rome, Rome

Ospedale San Pietro Fatebenefratelli, Rome

Switzerland

Ospedale Regionale Beata Vergine, Mendrisio

Key details

Sponsor

Ethicon, Inc.

Enrollment target

~195 participants

Started

September 2021

Primary completion

September 2036

Age range

21 Years and older

Sex

Female only

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov